Variation in uptake of sodium glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor analogues in adults with type 2 diabetes at high cardiovascular risk
Prevalent use of SGLT2i and GLP-1RA was suboptimal and varied across clinical characteristics and behavioural risk factors. While some variation reflects complexities in prescribing for this older population, there remains opportunity for optimised prescribing within this high-risk population.
Authors
- Jerry R. Greenfield (ORCID: https://orcid.org/0000-0002-0866-0973)
- Tamara Y. Milder (ORCID: https://orcid.org/0009-0002-0538-2661)
- Julian W. Sacre (ORCID: https://orcid.org/0000-0003-1315-3463)
- Brendon Lange Neuen (ORCID: https://orcid.org/0000-0001-9276-8380)
- Sallie‐Anne Pearson (ORCID: https://orcid.org/0000-0001-7137-6855)
- Jialing Lin (ORCID: https://orcid.org/0000-0002-0643-9191)
- Alys Havard (ORCID: https://orcid.org/0000-0001-6563-8804)
- Michael O. Falster (ORCID: https://orcid.org/0000-0001-6444-7272)
- Alice A. Gibson (ORCID: https://orcid.org/0000-0001-8750-9720)
- Juliana de Oliveira Costa (ORCID: https://orcid.org/0000-0002-8355-023X)
- Richard Osborne Day (ORCID: https://orcid.org/0000-0002-6045-6937)
- Jedidiah I Morton (ORCID: https://orcid.org/0000-0002-3231-5758)
Institutions
- The University of Sydney (AU)
- New South Wales Department of Health (AU)
- Garvan Institute of Medical Research (AU)
- Baker Heart and Diabetes Institute (AU)
- Royal North Shore Hospital (AU)
- UNSW Sydney (AU)
- St Vincent's Hospital Sydney (AU)
- The George Institute for Global Health (AU)
- Monash University (AU)
Publication Details
- Journal
- European Journal of Clinical Pharmacology
- Published
- 2025-06-30
- DOI
- https://doi.org/10.1007/s00228-025-03870-2
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29
Funders
- National Heart Foundation of Australia
- University of New South Wales